日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Clostridium botulinum UPF0297 protein CLI_2626 (CLI_2626) CSB-YP416083CWW
CSB-EP416083CWW
CSB-BP416083CWW
CSB-MP416083CWW
CSB-EP416083CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum V-type ATP synthase beta chain (atpB) CSB-YP416084CWW
CSB-EP416084CWW
CSB-BP416084CWW
CSB-MP416084CWW
CSB-EP416084CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP416085CWW
CSB-EP416085CWW
CSB-BP416085CWW
CSB-MP416085CWW
CSB-EP416085CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP416086CWW
CSB-EP416086CWW
CSB-BP416086CWW
CSB-MP416086CWW
CSB-EP416086CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribosomal protein L11 methyltransferase (prmA) CSB-YP416087CWW
CSB-EP416087CWW
CSB-BP416087CWW
CSB-MP416087CWW
CSB-EP416087CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum GTPase obg (obg) CSB-YP416088CWW
CSB-EP416088CWW
CSB-BP416088CWW
CSB-MP416088CWW
CSB-EP416088CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Threonine--tRNA ligase (thrS), partial CSB-YP416089CWW
CSB-EP416089CWW
CSB-BP416089CWW
CSB-MP416089CWW
CSB-EP416089CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Trigger factor (tig) CSB-YP416090CWW
CSB-EP416090CWW
CSB-BP416090CWW
CSB-MP416090CWW
CSB-EP416090CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP416091CWW
CSB-EP416091CWW
CSB-BP416091CWW
CSB-MP416091CWW
CSB-EP416091CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum DNA ligase (ligA), partial CSB-YP416092CWW
CSB-EP416092CWW
CSB-BP416092CWW
CSB-MP416092CWW
CSB-EP416092CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Tyrosine--tRNA ligase (tyrS) CSB-YP416093CWW
CSB-EP416093CWW
CSB-BP416093CWW
CSB-MP416093CWW
CSB-EP416093CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0042 nucleotide-binding protein CLI_3561 (CLI_3561) CSB-YP416094CWW
CSB-EP416094CWW
CSB-BP416094CWW
CSB-MP416094CWW
CSB-EP416094CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphoglucosamine mutase (glmM) CSB-YP416095CWW
CSB-EP416095CWW
CSB-BP416095CWW
CSB-MP416095CWW
CSB-EP416095CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L36 (rpmJ) CSB-YP416096CWW
CSB-EP416096CWW
CSB-BP416096CWW
CSB-MP416096CWW
CSB-EP416096CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S8 (rpsH) CSB-YP416097CWW
CSB-EP416097CWW
CSB-BP416097CWW
CSB-MP416097CWW
CSB-EP416097CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L29 (rpmC) CSB-YP416098CWW
CSB-EP416098CWW
CSB-BP416098CWW
CSB-MP416098CWW
CSB-EP416098CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S10 (rpsJ) CSB-YP416099CWW
CSB-EP416099CWW
CSB-BP416099CWW
CSB-MP416099CWW
CSB-EP416099CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L7/L12 (rplL) CSB-YP416100CWW
CSB-EP416100CWW
CSB-BP416100CWW
CSB-MP416100CWW
CSB-EP416100CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP416101CWW
CSB-EP416101CWW
CSB-BP416101CWW
CSB-MP416101CWW
CSB-EP416101CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Putative septation protein spoVG (spoVG) CSB-YP416102CWW
CSB-EP416102CWW
CSB-BP416102CWW
CSB-MP416102CWW
CSB-EP416102CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×